Johnson & Johnson reported a 5% increase in sales for the third quarter, reaching $23.8 billion, driven by strong demand in its pharmaceutical division.
AI Assistant
JOHNSON & JOHNSON
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.